KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $577,000 | +23.0% | 3,206 | -29.1% | 0.02% | +33.3% |
| Q2 2017 | $469,000 | +29.9% | 4,521 | -1.6% | 0.02% | +38.5% |
| Q1 2017 | $361,000 | +65.6% | 4,594 | -5.4% | 0.01% | +44.4% |
| Q4 2016 | $218,000 | -31.9% | 4,857 | -15.2% | 0.01% | -25.0% |
| Q3 2016 | $320,000 | +11.9% | 5,728 | +0.3% | 0.01% | -14.3% |
| Q2 2016 | $286,000 | +52.9% | 5,712 | +40.0% | 0.01% | +55.6% |
| Q1 2016 | $187,000 | -31.8% | 4,080 | -8.3% | 0.01% | -30.8% |
| Q4 2015 | $274,000 | +10.9% | 4,451 | +0.4% | 0.01% | +8.3% |
| Q3 2015 | $247,000 | – | 4,434 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |